SERRA MCGUIRE: Open Payments
NPI 1710531900 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,299 in 66 payments from 23 companies in 2025. Trend: 2023 $2,372 · 2024 $2,266 · 2025 $1,299
Food & beverage: $1,299
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $328 |
| Teva Pharmaceuticals USA, Inc. | 4 | $114 |
| Novartis Pharmaceuticals Corporation | 4 | $96 |
| PFIZER INC. | 4 | $85 |
| Grifols USA, LLC | 3 | $80 |
| CSL Behring | 3 | $77 |
| SK Life Science, Inc. | 3 | $75 |
| Eisai Inc. | 3 | $73 |
| Biogen, Inc. | 3 | $63 |
| Axsome Therapeutics, Inc. | 2 | $38 |
Products named: BOTOX, KESIMPTA, Leqembi, UBRELVY, AJOVY, Gamunex-C, Hizentra, QULIPTA.
Industry payments across TX — which companies pay providers there.
